Company news

Abbisko Cayman Limited news in 2024

Abbisko Cayman Limited's news releases, calls and decks from 2024, newest first.

View company

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）

January 8, 2024

Decks in 2024